Metlife (MET-PA) Notes Payables (2009 - 2026)

Metlife's Notes Payables history runs 18 years deep, the most recent figure standing at $404.0 million for Q1 2026.

• In Q1 2026, Notes Payables rose 6.04% year-over-year to $404.0 million; the TTM figure through Mar 2026 stood at $404.0 million (up 6.04% YoY), while the FY2025 annual figure was $355.0 million, down 23.66% from the prior year.
• Notes Payables was $404.0 million for Q1 2026 at Metlife, up from $355.0 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $465.0 million in Q4 2024 to a low of $119.0 million in Q4 2023.
• Historically, Notes Payables has averaged $282.8 million across 5 years, with a median of $323.0 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Notes Payables slumped 50.13% in 2022, then soared 290.76% in 2024.
• A 5-year view of Notes Payables shows it stood at $175.0 million in 2022, then tumbled by 32.0% to $119.0 million in 2023, then jumped by 290.76% to $465.0 million in 2024, then decreased by 23.66% to $355.0 million in 2025, then climbed by 13.8% to $404.0 million in 2026.
• The last three Notes Payables figures came in at $404.0 million (Q1 2026), $355.0 million (Q4 2025), and $378.0 million (Q3 2025), per Business Quant data.